Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Establishment of a Prenatal Diagnosis Schedule As Part of a Prophylaxis Program of Factor Xiii Deficiency in the Southeast of Iran Publisher Pubmed



Naderi M1 ; Reykande SE2 ; Dorgalaleh A3, 4 ; Alizadeh S3 ; Tabibian S3 ; Einollahi N5 ; Moghaddam EM6
Authors

Source: Blood Coagulation and Fibrinolysis Published:2016


Abstract

Factor XIII deficiency (FXIIID) is an extremely rare bleeding disorder with a prevalence of 1 in 3 million in the general population. Compared to its global incidence, it has the greatest prevalence in Sistan and Baluchistan Province in the southeast of Iran. The high incidence of FXIIID in this region causes a high rate of morbidity and mortality among the affected individuals because of life-threatening episodes such as central nervous system (CNS) bleeding, umbilical cord bleeding, as well as miscarriage. CNS bleeding leads to a considerable number of neurological and behavioral complications. Therefore, we have designed an established prenatal diagnosis (PND) program to prevent the increasing incidence of life-threatening bleeding episodes and related complications among neonates with congenital FXIIID. This study was conducted from September 2013 to August 2014. A consent form was signed by the parents. Fetal sampling was done via abdominal chorionic villus sampling passage under local anesthesia and ultrasonic guidance within the first trimester of pregnancy. Fetal DNA was extracted, and PCR-restriction fragment length polymorphism was performed for the only reported mutation of FXIII (Trp187Arg) in the southeast of Iran. During the period of study, PND was performed on eight fetuses. Six fetuses were offspring of parental consanguineous marriages, and all of them had a positive family history of FXIIID. Seven out of the eight fetuses had a family member with CNS bleeding due to FXIIID. Four fetuses had a FXIIID-related death. One of the fetuses bore homozygous Trp187Arg mutation, whereas six were heterozygous, and one of the mothers gave birth to an unaffected fetus. To the best of our knowledge, PND is a possible solution to control high incidence of lifethreatening episodes of FXIIID in southeast Iran. © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Related Docs
View other Related Docs
1. Factor Xiii Deficiency in Iran: A Comprehensive Review of the Literature, Seminars in Thrombosis and Hemostasis (2015)
2. First Cases of Severe Congenital Factor Xiii Deficiency in Southwestern Afghanistan in the Vicinity of Southeast of Iran, Blood Coagulation and Fibrinolysis (2015)
3. Central Nervous System Bleeding in Pediatric Patients With Factor Xiii Deficiency: A Study on 23 New Cases, Hematology (2015)
Experts (# of related papers)
View all Related Experts
Shaban Alizadeh (10)
Zahra Kashanikhatib (3)
Other Related Docs
4. Association Between Expression of Mmp-2 and Mmp-9 Genes and Pathogenesis of Intracranial Hemorrhage in Severe Coagulation Factor Xiii Deficiency, Hematology (United Kingdom) (2015)
5. Coagulation Factor Xiii-A A614t Gene Variation Is Suggestive of Founder Effect in Iranian Patients With Sever Congenital Factor Xiii Deficiency, Journal of Cellular and Molecular Anesthesia (2016)
6. Diagnosis of Factor Xiii Deficiency, Hematology (2016)
7. Relationship Between the Matrix Metalloproteinases and the Occurrence of Central Nervous System Bleeding in Factor Xiii Deficiency, Journal of Isfahan Medical School (2015)
8. Spectrum of Factor X Gene Mutations in Iranian Patients With Congenital Factor X Deficiency, Blood Coagulation and Fibrinolysis (2016)
9. Congenital Factor Xi Deficiency, Complete Genotype and Phenotype of Two Iranian Families, Blood Coagulation and Fibrinolysis (2019)
10. Guidelines for Laboratory Diagnosis of Factor Xiii Deficiency, Blood Coagulation and Fibrinolysis (2016)
11. Expression and Methylation Status of Vascular Endothelial Growth Factor and Thrombospondin-1 Genes in Congenital Factor Xiii-Deficient Patients With Intracranial Hemorrhage, Blood Coagulation and Fibrinolysis (2021)
12. Expression and Cpg Island Methylation Pattern of Mmp-2 and Mmp-9 Genes in Patients With Congenital Factor Xiii Deficiency and Intracranial Hemorrhage, Hematology (United Kingdom) (2019)
13. Subarachnoid Hemorrhage in Congenital Factor X Deficiency: A Case Study and Literature Review, Iranian Red Crescent Medical Journal (2016)
14. Diagnosis, Clinical Manifestations and Management of Rare Bleeding Disorders in Iran, Hematology (2017)
15. A Survey of the Common Mutations and Ivs8-Tn Polymorphism of Cystic Fibrosis Transmembrane Conductance Regulator Gene in Infertile Men With Nonobstructive Azoospermia and Cbavd in Iranian Population, Iranian Biomedical Journal (2019)
16. Genetic Investigation of 261 Cases of Turner Syndrome Patients Referred to the Genetic Clinic, Iranian Journal of Public Health (2021)
17. A New Mutation in Ntrk1 Gene Is Associated With Congenital Insensitivity to Pain Without Anhidrosis, The Neurobiology# Physiology# and Psychology of Pain (2021)
18. Comparison of Risk Factors Related to Intraventricular Hemorrhage Between Preterm Infants Born After Normal and in Vitro Fertilization Conceptions, Iranian Journal of Child Neurology (2019)
19. Congenital Factor V Deficiency: Comparison of the Severity of Clinical Presentations Among Patients With Rare Bleeding Disorders, Acta Haematologica (2015)
20. Chorioamnionitis and Neonates; Which Strategy?, Archives of Iranian Medicine (2020)